Douglas Walsh Hobbs

This inventor holds 25 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 13 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Schering Corporation, Pharmacopeia Drug Discovery, Inc., Merck Sharp + Dohme Corp.. Active years: 2005-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Douglas Walsh Hobbs. Retrieved from https://idiyas.com/inventor/douglas-walsh-hobbs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 1)

% Patents Active = 80.0

CIPO Patents = 2

EPO Patents = 13 (Patent Applications = 2)

Average Co-Inventor Count = 8.0

ph-index = 8

Forward Citations = 231(Granted Patents)

Location History:

Chesterfield, MS (US) (2011)
Yardley, PA (US) (2005 - 2014)
Chesterfield, MO (US) (2010 - 2015)

Company Filing History:

Pharmacopeia Drug Discovery, Inc.

patents

4 out of 2,405

Merck Sharp + Dohme Corp.

Pharacopeia Drug Discovery, Inc.

patent

where one patent can have more than one assignee

Years Active: 2005-2015

Loading Chart...

Areas of Expertise:

BACE-1 Inhibitors

CXCR3 Antagonists

Cyclin Dependent Kinase

Heterocyclic Compounds

Piperazine

Pyrazolopyrimidines

Melanin Concentrating Hormone

Obesity Treatment

Aryl Compounds

Biaryl Compounds

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9062007 - Cyclic amide BACE-1 inhibitors having a benzamide substituent (2015-06-23),

2. 8673924 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors (2014-03-18),

3. 8623867 - Cyclic amine BACE-1 inhibitors having a benzamide substituent (2014-01-07),

4. 8278334 - Cyclic amine BACE-1 inhibitors having a benzamide substituent (2012-10-02),

5. 8207170 - Heterocyclic substituted piperazines with CXCR3 antagonist activity (2012-06-26),

6. 8017616 - Heterocyclic substituted pyridine compounds with CXCR3 antagonist activity (2011-09-13),

7. 7902199 - Heterocyclic substituted piperazine compounds with CXCR3 antagonist activity (2011-03-08),

8. 7868006 - Heterocyclic substituted piperazines with CXCR3 antagonist activity (2011-01-11),

9. 7868005 - Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity (2011-01-11),

10. 7807683 - N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors (2010-10-05),

11. 7799789 - Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity (2010-09-21),

12. 7786124 - Heterocyclic substituted pyridine compounds with CXCR3 antagonist activity (2010-08-31),

13. 7776862 - Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity (2010-08-17),

14. 7763616 - Piperazine-piperidines with CXCR3 antagonist activity (2010-07-27),

15. 7662816 - Cyclic amine BACE-1 inhibitors having a benzamide substituent (2010-02-16),

Title: The Innovative Mind of Douglas Walsh Hobbs

Introduction: Douglas Walsh Hobbs, a distinguished inventor hailing from Yardley, PA (US), is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Douglas Walsh Hobbs holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: With a career spanning over two decades, Douglas Walsh Hobbs has consistently pushed the boundaries of technological advancement. His work has revolutionized industries such as telecommunications, robotics, and renewable energy.

Collaborations: Throughout his career, Douglas Walsh Hobbs has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work in multidisciplinary teams has led to the development of cutting-edge technologies.

Conclusion: In conclusion, Douglas Walsh Hobbs stands as a beacon of innovation in the world of technology. His relentless pursuit of excellence and passion for creating solutions that make a difference have solidified his position as a visionary inventor in Yardley, PA (US).

Profile summary based on public USPTO records.